Published in Am J Physiol Cell Physiol on October 16, 2013
Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol (2015) 0.91
Alterations in cancer cell mechanical properties after fluid shear stress exposure: a micropipette aspiration study. Cell Health Cytoskelet (2015) 0.89
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Pharmacol Rev (2016) 0.84
Microenvironment of tumor-draining lymph nodes: opportunities for liposome-based targeted therapy. Int J Mol Sci (2014) 0.84
Hyaluronan regulation of endothelial barrier function in cancer. Adv Cancer Res (2014) 0.83
A physical sciences network characterization of circulating tumor cell aggregate transport. Am J Physiol Cell Physiol (2015) 0.83
Unnatural killer cells to prevent bloodborne metastasis: inspiration from biology and engineering. Expert Rev Anticancer Ther (2014) 0.80
Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies. J Biomed Mater Res A (2015) 0.80
Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow. Biomaterials (2015) 0.78
Apparent exchange rate for breast cancer characterization. NMR Biomed (2016) 0.77
Lamin A/C deficiency reduces circulating tumor cell resistance to fluid shear stress. Am J Physiol Cell Physiol (2015) 0.77
Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis. Nat Commun (2017) 0.75
Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells. Cell Mol Bioeng (2017) 0.75
The role of shear stress and altered tissue properties on endothelial to mesenchymal transformation and tumor-endothelial cell interaction. Biomicrofluidics (2017) 0.75
Inflammation and cancer. Nature (2002) 53.78
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Adhesion receptors of the immune system. Nature (1990) 28.86
Immunity, inflammation, and cancer. Cell (2010) 28.27
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell (1994) 27.85
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
Wound healing--aiming for perfect skin regeneration. Science (1997) 16.08
A perspective on cancer cell metastasis. Science (2011) 13.31
Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 12.29
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A (2007) 11.94
Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell (1991) 11.89
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013) 10.87
Breast cancer metastasis: markers and models. Nat Rev Cancer (2005) 9.93
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell (1991) 7.29
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest (1994) 7.25
Circulating tumor cells: approaches to isolation and characterization. J Cell Biol (2011) 6.54
Determinants of tumor blood flow: a review. Cancer Res (1988) 5.56
Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol (2000) 5.26
Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J (2005) 4.91
Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer (2002) 4.76
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med (2000) 4.40
Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett (2007) 4.35
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev (1991) 3.93
Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol (2012) 3.51
Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A (2007) 3.48
The endothelial surface layer. Pflugers Arch (2000) 3.40
The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng (2007) 3.40
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem (1999) 3.34
The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch (2007) 3.31
Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res (1992) 3.09
Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci U S A (2003) 2.93
Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res (1996) 2.93
Neutrophils roll on E-selectin. J Immunol (1993) 2.91
Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem (2007) 2.67
Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci U S A (2010) 2.62
Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res (2006) 2.61
Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem (2001) 2.45
The endothelial glycocalyx protects against myocardial edema. Circ Res (2003) 2.40
Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol (2000) 2.33
Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol (2002) 2.27
Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol (1999) 2.25
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res (2001) 2.12
Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation (2007) 2.11
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem (2003) 2.08
Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med (1993) 2.03
The anthracycline antineoplastic drugs. N Engl J Med (1981) 2.02
Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res (1998) 2.01
Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem (1997) 2.00
Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices (2009) 2.00
Quantitation of L-selectin distribution on human leukocyte microvilli by immunogold labeling and electron microscopy. J Histochem Cytochem (1996) 1.97
Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Res (1999) 1.92
Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol (2003) 1.84
Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer (2012) 1.78
Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. J Biol Chem (1977) 1.77
TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol (2000) 1.76
Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest (1997) 1.75
Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem (2000) 1.75
Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol (2004) 1.75
Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol (2001) 1.73
Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol (2010) 1.73
Circulating breast cancer cells are frequently apoptotic. Am J Pathol (2001) 1.72
Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models. Mol Cancer Ther (2010) 1.68
Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev (1995) 1.66
Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol (2002) 1.66
Microvascular hematocrit and red cell flow in resting and contracting striated muscle. Am J Physiol (1979) 1.63
Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol (2004) 1.63
Hyaluronan in human malignancies. Exp Cell Res (2010) 1.63
Dynamic contact forces on leukocyte microvilli and their penetration of the endothelial glycocalyx. Biophys J (2001) 1.58
Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest (1993) 1.56
Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest (1992) 1.55
Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J Biol Chem (1983) 1.55
Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol (2008) 1.52
Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene (2013) 1.48
Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am J Physiol (1990) 1.47
Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res (2004) 1.44
Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc Res (1997) 1.42
Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res (1999) 1.41
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci U S A (2009) 1.40
Direct measurement of microvessel hematocrit, red cell flux, velocity, and transit time. Am J Physiol (1982) 1.38
Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol (1996) 1.38
The production of hyaluronate by spontaneously established cell lines and viral transformed lines of fibroblastic origin. Biochim Biophys Acta (1965) 1.33
Blood viscosity, mass transport, and thrombogenesis. Prog Hemost Thromb (1982) 1.33
Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer (1997) 1.29
A new view of Starling's hypothesis at the microstructural level. Microvasc Res (1999) 1.29
Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis (2007) 1.29
Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med (1996) 1.27
E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer (1995) 1.27
Scanning angle interference microscopy reveals cell dynamics at the nanoscale. Nat Methods (2012) 1.25
Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res (2001) 1.25
Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol (1997) 1.25
Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions. J Histochem Cytochem (2008) 1.23
Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle (2006) 1.21
The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem (2012) 1.18
Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. Cancer Discov (2011) 1.17
Deformability considerations in filtration of biological cells. Lab Chip (2010) 1.17
Mechanical shedding of L-selectin from the neutrophil surface during rolling on sialyl Lewis x under flow. J Biol Chem (2006) 1.17
Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol Bioeng (2009) 1.11
Altered hyaluronan biosynthesis in cancer progression. Semin Cancer Biol (2008) 1.09
HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem (2006) 1.08
Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration. Sci Transl Med (2011) 2.35
Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clin Chem (2012) 1.97
Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J Exp Med (2008) 1.76
The state diagram for cell adhesion mediated by two receptors. Biophys J (2003) 1.58
A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33
Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging. Biophys J (2008) 1.32
Platelet adhesive dynamics. Part I: characterization of platelet hydrodynamic collisions and wall effects. Biophys J (2008) 1.32
Adhesive dynamics simulations of the shear threshold effect for leukocytes. Biophys J (2006) 1.31
TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc Natl Acad Sci U S A (2014) 1.31
Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps. Infect Immun (2011) 1.25
Interlaboratory comparison of backscatter coefficient estimates for tissue-mimicking phantoms. Ultrason Imaging (2010) 1.25
Mechanics of transient platelet adhesion to von Willebrand factor under flow. Biophys J (2004) 1.24
Mechanical shedding of L-selectin from the neutrophil surface during rolling on sialyl Lewis x under flow. J Biol Chem (2006) 1.17
PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation. J Cell Biol (2011) 1.15
Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2009) 1.13
Glycomechanics of the metastatic cascade: tumor cell-endothelial cell interactions in the circulation. Ann Biomed Eng (2011) 1.13
Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol Bioeng (2009) 1.11
Use of naturally occurring halloysite nanotubes for enhanced capture of flowing cells. Langmuir (2010) 1.06
Nanobiotechnology for the capture and manipulation of circulating tumor cells. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.06
P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow. Clin Chem (2007) 1.04
Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion. PLoS One (2013) 1.02
Continuously perfused microbubble array for 3D tumor spheroid model. Biomicrofluidics (2011) 1.01
Three to Tango: MUC1 as a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic Cascade. Front Oncol (2012) 1.01
Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. Carbohydr Res (2010) 1.00
Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors. New J Phys (2013) 0.99
Influence of Brownian motion on blood platelet flow behavior and adhesive dynamics near a planar wall. Langmuir (2007) 0.98
E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J Control Release (2012) 0.97
Circulating tumor cells: the substrate of personalized medicine? Front Oncol (2012) 0.97
Analysis of human fibroadenomas using three-dimensional impedance maps. IEEE Trans Med Imaging (2011) 0.96
Microcontact printing of P-selectin increases the rate of neutrophil recruitment under shear flow. Biotechnol Prog (2009) 0.96
Multiscale modeling of platelet adhesion and thrombus growth. Ann Biomed Eng (2012) 0.96
Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device. Br J Haematol (2008) 0.95
Differential dynamics of platelet contact and spreading. Biophys J (2012) 0.95
Covalent immobilization of p-selectin enhances cell rolling. Langmuir (2007) 0.95
Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol (2013) 0.95
Adhesion receptors as therapeutic targets for circulating tumor cells. Front Oncol (2012) 0.95
Rapid isolation of viable circulating tumor cells from patient blood samples. J Vis Exp (2012) 0.93
Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3. Am J Pathol (2011) 0.92
Microfabrication of cavities in polydimethylsiloxane using DRIE silicon molds. Lab Chip (2007) 0.91
Shear-induced resistance to neutrophil activation via the formyl peptide receptor. Biophys J (2012) 0.91
Role of c-Abl in L-selectin shedding from the neutrophil surface. Blood Cells Mol Dis (2011) 0.89
Investigating the feasibility of stem cell enrichment mediated by immobilized selectins. Biotechnol Prog (2007) 0.88
Fluid shear stress increases neutrophil activation via platelet-activating factor. Biophys J (2014) 0.87
Interviewing the incarcerated offender convicted of sexually assaulting the elderly. J Forensic Nurs (2006) 0.86
Stem cell enrichment with selectin receptors: mimicking the pH environment of trauma. Sensors (Basel) (2013) 0.86
Inducing apoptosis in rolling cancer cells: a combined therapy with aspirin and immobilized TRAIL and E-selectin. Mol Pharm (2012) 0.86
Multiscale model of platelet translocation and collision. J Comput Phys (2013) 0.85
Nanoparticle coatings for enhanced capture of flowing cells in microtubes. ACS Nano (2010) 0.84
Effect of extracellular pH on selectin adhesion: theory and experiment. Biophys J (2013) 0.84
Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines. Biomaterials (2012) 0.84
Microenvironment induced spheroid to sheeting transition of immortalized human keratinocytes (HaCaT) cultured in microbubbles formed in polydimethylsiloxane. Biomaterials (2011) 0.83
Purification of CD45+ hematopoietic cells directly from human bone marrow using a flow-based P-selectin-coated microtube. Am J Hematol (2008) 0.82
Rapid enrichment of biomolecules using simultaneous liquid and particulate dielectrophoresis. Lab Chip (2009) 0.82
Cooperative effects of matrix stiffness and fluid shear stress on endothelial cell behavior. Biophys J (2015) 0.81
Leukocytes as carriers for targeted cancer drug delivery. Expert Opin Drug Deliv (2014) 0.81
Simulation of platelet, thrombus and erythrocyte hydrodynamic interactions in a 3D arteriole with in vivo comparison. PLoS One (2013) 0.80
Unnatural killer cells to prevent bloodborne metastasis: inspiration from biology and engineering. Expert Rev Anticancer Ther (2014) 0.80
A microfluidic device to select for cells based on chemotactic phenotype. Technology (Singap World Sci) (2014) 0.79
P-selectin-coated microtube for the purification of CD45+ hematopoietic cells directly from human peripheral blood. Blood Cells Mol Dis (2009) 0.79
An integrated stochastic model of "inside-out" integrin activation and selective T-lymphocyte recruitment. Langmuir (2012) 0.79
The distribution of rolling neutrophils in venular convergences. Biorheology (2005) 0.79
Shear-induced capping of L-selectin on the neutrophil surface during centrifugation. J Immunol Methods (2007) 0.79
Targeting Underglycosylated MUC1 for the Selective Capture of Highly Metastatic Breast Cancer Cells Under Flow. Cell Mol Bioeng (2013) 0.78
Hydrogen sulfide reduces neutrophil recruitment in hind-limb ischemia-reperfusion injury in an L-selectin and ADAM-17-dependent manner. Plast Reconstr Surg (2013) 0.77
Multiscale systems biology: a special issue devoted to understanding biology and medicine across multiple scales. Ann Biomed Eng (2012) 0.76
Deformable cell-cell and cell-substrate interactions in semi-infinite domain. J Biomech (2013) 0.75
Microvascular endothelial cells exhibit optimal aspect ratio for minimizing flow resistance. Ann Biomed Eng (2008) 0.75
Hydrodynamic recruitment of rolling leukocytes in vitro. Biophys J (2003) 0.75
Adhesive dynamics simulations of the mechanical shedding of L-selectin from the neutrophil surface. J Theor Biol (2009) 0.75
Do blood capillaries exhibit optimal bumpiness? J Theor Biol (2007) 0.75
Completing self-assessment modules during residency is associated with better certification exam results. Fam Med (2014) 0.75
Intraoperative Esmolol as an Adjunct for Perioperative Opioid and Postoperative Pain Reduction: A Systematic Review, Meta-analysis, and Meta-regression. Anesth Analg (2017) 0.75
A theme series on physical biology in cancer in AJP-Cell. Am J Physiol Cell Physiol (2013) 0.75